Pharma And Biotech Funds Add Zest To Your Portfolio
John Dowdee - at Seeking Alpha - Fri Feb 13, 7:10AM CST
PBE: 52.78 (+0.30), HQL: 27.40 (+0.16), FBT: 110.21 (+1.02), PJP: 73.81 (+0.69), XBI: 203.40 (+1.36), XPH: 118.58 (+0.98), IBB: 323.46 (+3.04), HQH: 34.20 (+0.06)
Where Do Cures Reside? The Answer Is In Regenerative Medicine
Life Sciences Report - Seeking Alpha - Fri Jan 09, 7:37AM CST
The practice of medicine is being transformed. The journey has been arduous, but revolutionary stem cell, gene and immunocellular therapies are rapidly moving toward pivotal milestones-and investors in the space should strap in for a rewarding joy...
BBP: 28.36 (+0.12), RXL: 131.80 (+1.10), XBI: 203.40 (+1.36), IHE: 163.48 (+1.38), IHF: 123.33 (-0.30), PPH: 67.69 (+0.60), XHE: 91.74 (+0.76), BBC: 28.98 (+0.18), PTH: 56.26 (+0.35), BBH: 122.45 (+0.86), FHLC: 34.19 (+0.16), IHI: 117.25 (+0.94), CURE: 135.77 (+1.84), FXH: 62.97 (+0.34), VHT: 130.56 (+0.66), RYH: 148.64 (+0.75), PBE: 52.78 (+0.30), IYH: 149.63 (+0.84), FBT: 110.21 (+1.02), XHS: 116.43 (-0.07), XPH: 118.58 (+0.98), XLV: 70.72 (+0.28), SBIO: 27.28 (+0.14), PSCH: 63.77 (+0.26), PJP: 73.81 (+0.69), RXD: 13.98 (-0.26)
Kyle Bass's Assault On Pharma Patents
IP Hawk - at Seeking Alpha - Thu Jan 08, 12:25PM CST
BBP: 28.36 (+0.12), RXL: 131.80 (+1.10), XBI: 203.40 (+1.36), IBB: 323.46 (+3.04), IHE: 163.48 (+1.38), IHF: 123.33 (-0.30), BBC: 28.98 (+0.18), PPH: 67.69 (+0.60), XHE: 91.74 (+0.76), PTH: 56.26 (+0.35), BBH: 122.45 (+0.86), FHLC: 34.19 (+0.16), IHI: 117.25 (+0.94), CURE: 135.77 (+1.84), FXH: 62.97 (+0.34), VHT: 130.56 (+0.66), RYH: 148.64 (+0.75), PBE: 52.78 (+0.30), IYH: 149.63 (+0.84), FBT: 110.21 (+1.02), XHS: 116.43 (-0.07), XPH: 118.58 (+0.98), XLV: 70.72 (+0.28), SBIO: 27.28 (+0.14), PSCH: 63.77 (+0.26), PJP: 73.81 (+0.69), RXD: 13.98 (-0.26)
2015 Biotech Stock Preview: Rhythms Of The 'PermaBull'
Rod Raynovich - Seeking Alpha - Tue Jan 06, 2:33PM CST
2015: Another Good Year Unless "Something Happens" Life Science stocks had another big year in 2014 up 48% tracking gains for the overall healthcare sector up 35%. Over 10 years the return is 300%! The move up was not a straight line as...
ESRX: 84.90 (+0.40), GILD: 101.90 (+1.10), FBT: 110.21 (+1.02), ABBV: 58.05 (+1.00), XLV: 70.72 (+0.28)
3 Biotech ETF Winners from 2014's Best Performing Sector - ETF News And Commentary
Zacks Equity Research - ZACKS - Tue Jan 06, 9:00AM CST
Can these biotech ETFs match their 2014 performance this year?
PBE: 52.78 (+0.30), FBT: 110.21 (+1.02), XBI: 203.40 (+1.36)
Market Beating Sector ETFs of 2014 - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Wed Dec 31, 12:00PM CST
These sector ETFs are clearly the winners of 2014.
XTN: 106.48 (+0.70), PSI: 26.30 (-0.18), FBT: 110.21 (+1.02)
ALPS will launch a medical breakthroughs ETF tomorrow
Seeking Alpha - at Seeking Alpha - Tue Dec 30, 12:49PM CST
BBP: 28.36 (+0.12), PBE: 52.78 (+0.30), BBC: 28.98 (+0.18), SBIO: 27.28 (+0.14), FBT: 110.21 (+1.02), XBI: 203.40 (+1.36), BBH: 122.45 (+0.86)
Gilead, Abbvie, Express Scripts, And Biotech Industry Turmoil Seen By Market-Makers
Peter F. Way, CFA - Seeking Alpha - Wed Dec 24, 8:33AM CST
This is a market price forecast analysis It is not an analysis of medical technology, competition, or economics. We have limited competence in those areas. But we do have extensive experience in how market professionals have interpreted the likely...
ESRX: 84.90 (+0.40), GILD: 101.90 (+1.10), FBT: 110.21 (+1.02), BIB: 141.30 (+2.39), XBI: 203.40 (+1.36), IBB: 323.46 (+3.04), BBH: 122.45 (+0.86), ABBV: 58.05 (+1.00)
Inside The 2 New Innovative Biotech ETFs From BioShares
Zacks Funds - Seeking Alpha - Tue Dec 23, 2:00PM CST
The biotechnology corner of the broader health care industry has been one of the best performing U.S. sectors this year despite some temporary glitches and rough trading in between. Encouraging industry trends, increasing merger and acquisition...
BBP: 28.36 (+0.12), BBC: 28.98 (+0.18), FBT: 110.21 (+1.02), XBI: 203.40 (+1.36), IBB: 323.46 (+3.04)
Inside the Two New Innovative Biotech ETFs from BioShares - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 7:02AM CST
Two interesting ETFs hit the market from BioShares targeting Clinical Trials and Biotechnology Products.
BBP: 28.36 (+0.12), BBC: 28.98 (+0.18), FBT: 110.21 (+1.02), XBI: 203.40 (+1.36), IBB: 323.46 (+3.04)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds
Business Wire - Mon Dec 22, 4:36PM CST
First Trust Advisors L.P. ("FTA"
FPE: 19.17 (+0.04), FTSL: 49.10 (+0.05), AIRR: 18.17 (+0.23), QABA: 35.79 (+0.05), FEUZ: 32.37 (+0.11), FTSM: 60.00 (unch), GRID: 35.50 (+0.01), QTEC: 44.20 (+0.37), FV: 23.10 (+0.17), FPXI: 28.37 (+0.42), IFV: 19.26 (+0.01), FDIV: 50.40 (+0.13), FMK: 27.21 (+0.19), PLTM: 10.63 (+0.30), QQXT: 41.19 (+0.33), RDVY: 22.49 (+0.17), BICK: 23.99 (+0.27), CARZ: 39.60 (+0.42), TDIV: 28.44 (+0.22), HYLS: 50.48 (+0.38), MDIV: 21.48 (+0.04), CU: 17.35 (+0.60), FBT: 110.21 (+1.02), QQEW: 44.03 (+0.43), FEMB: 47.50 (-1.06), YDIV: 19.40 (+0.11), FMB: 51.97 (-0.03), FTHI: 20.93 (+0.09), FLM: 44.03 (-0.37), FTLB: 20.74 (+0.07), QCLN: 18.05 (+0.09), QINC: 21.72 (+0.12), FTCS: 38.89 (+0.07), FONE: 39.76 (+0.10), SKYY: 29.40 (+0.18), LMBS: 50.72 (+0.37)
Top Performing ETFs Of 2014 And 3 Great Picks For Next Year
Zacks Funds - Seeking Alpha - Fri Dec 19, 1:24PM CST
Stocks started off the year with a pretty solid performance, as the S&P 500 posted a gain of about 6% in the first half of the year. With a move like that and few worries on the horizon, many thought that another double digit performance was in...
PSI: 26.30 (-0.18), JO: 29.81 (-0.02), OIH: 36.16 (+0.87), IAI: 42.04 (-0.19), FBT: 110.21 (+1.02), SCIN: 18.05 (+0.18), SMIN: 36.21 (+0.36), IYC: 142.85 (+0.77), CHNA: 35.95 (+0.47), INCO: 36.83 (+0.29), CAFE: 20.95 (+1.13), ASHR: 35.67 (+0.29)
LifeSci Index Partners launches 2 new biotech ETFs
Seeking Alpha - at Seeking Alpha - Wed Dec 17, 9:51AM CST
BBP: 28.36 (+0.12), PBE: 52.78 (+0.30), BBC: 28.98 (+0.18), FBT: 110.21 (+1.02), XBI: 203.40 (+1.36), BBH: 122.45 (+0.86)
Biotech ETFs in Focus on Cubist Takeover Deal - ETF News And Commentary
Sweta Killa - ZACKS - Tue Dec 09, 1:00PM CST
The Cubist takeover by Merck was well received by investors, pushing the stock and the biotech ETFs higher.
CBST: 101.94 (+0.14), FBT: 110.21 (+1.02), MRK: 58.81 (-0.07), IBB: 323.46 (+3.04), BBH: 122.45 (+0.86)
Give Special Thanks To These 3 ETFs
Zacks Funds - at Seeking Alpha - Sat Nov 29, 3:50PM CST
Originally published on November 26, 2014 Americans are ready for plateful food and cartful shopping as it’s time for Thanksgiving. The celebration of bounty and gratitude is in full swing in the investment world as well. This is because...
XTN: 106.48 (+0.70), REZ: 62.12 (-0.41), FBT: 110.21 (+1.02)
How Much Is The Biotech Industry Stretched?
Fred Piard - at Seeking Alpha - Fri Nov 28, 7:11AM CST
BIIB: 391.66 (-0.45), GILD: 101.90 (+1.10), FBT: 110.21 (+1.02), XBI: 203.40 (+1.36), IBB: 323.46 (+3.04), AMGN: 153.48 (+0.30), CELG: 115.88 (+0.16)